HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katherine F Liau Selected Research

Capecitabine (Xeloda)

10/2010A phase I study of sunitinib plus capecitabine in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katherine F Liau Research Topics

Disease

2Breast Neoplasms (Breast Cancer)
06/2011 - 04/2011
2Hypertension (High Blood Pressure)
10/2008 - 11/2007
1Ulcerative Colitis
07/2023
1Crohn Disease (Crohn's Disease)
07/2023
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
07/2023
1Melanoma (Melanoma, Malignant)
12/2011
1Neutropenia
04/2011
1Neoplasms (Cancer)
10/2010
1Thyroid Neoplasms (Thyroid Cancer)
10/2008
1Renal Cell Carcinoma (Grawitz Tumor)
11/2007

Drug/Important Bio-Agent (IBA)

4Axitinib (AG 013736)IBA
12/2011 - 11/2007
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2011 - 11/2007
2Sunitinib (Sutent)FDA Link
04/2011 - 10/2010
1Biosimilar PharmaceuticalsIBA
07/2023
1Infliximab (Remicade)FDA Link
07/2023
1CT-P13IBA
07/2023
1Docetaxel (Taxotere)FDA Link
06/2011
1Paclitaxel (Taxol)FDA LinkGeneric
04/2011
1Bevacizumab (Avastin)FDA Link
04/2011
1taxaneIBA
04/2011
1Capecitabine (Xeloda)FDA Link
10/2010
1IodineIBA
10/2008
1Antihypertensive Agents (Antihypertensives)IBA
11/2007
1CytokinesIBA
11/2007

Therapy/Procedure

1Therapeutics
10/2008